Advisory Board and Editors Genomics

Journal Factsheet
A one-page PDF to help when considering journal options with co-authors
Download Factsheet
I told my colleagues that PeerJ is a journal where they need to publish if they want their paper to be published quickly and with the strict peer review expected from a good journal.
Sohath Vanegas,
PeerJ Author
View author feedback

Emiliano Maiani

Emiliano Maiani earned his MS and PhD in Molecular and Cellular Biology at the University of Rome “Tor Vergata”, Rome, Italy. In 2013, he joined the Cell Stress and Survival laboratory headed by prof. Francesco Cecconi at the Danish Cancer Society Research Center (DCRC), Copenhagen, Denmark. At the end of 2017, he moved for a second postdoc at the Computational Biology Laboratory headed by Elena Papaleo at the DCRC, Copenhagen. In this period, he expanded his knowledge to computational and structural biology. His research is focused on cancer biology and in particular in autophagy and DNA damage response pathways.

Ian J Majewski

My research group is working to identify genetic mutations that contribute to the development of leukaemia, and studying how these mutations influence a patient’s response to therapy. The cancer landscape is both complex and dynamic and we're using genomic approaches to study how cancer cells evolve in response to treatment.

Thulani P Makhalanyane

Thulani Makhalanyane is an Associate Professor in the Department of Biochemistry, Genetics and Microbiology and undertakes research at the Centre for Microbial Ecology and Genomics. His research has focused almost entirely on understanding the ecology of microbial communities in extreme environments.

Safarina G Malik

Safarina G. Malik is a Principal Investigator at the Genome Diversity and Disease Division of the Mochtar Riady Institute for Nanotechnology, Tangerang, Banten, Indonesia, since January 2022. From 2011 to 2021 she lead the Lifestyle Diseases Research Group at the Eijkman Institute for Molecular Biology, Jakarta, Indonesia. Her key research topics and expertise include genetic diversity, microbiome, mitochondrial genetics and dysfunction, medical genetics, lifestyle disease association, nutrigenetics-nutrigenomics, population genetics and evolution.

Julin N Maloof

Professor of Plant Biology and member of the Genome Center, University of California, Davis.

Elected Fellow, AAAS

Postdoctoral training at The Salk Institute. Doctoral Training at UCSF

Corinne F Maurice

CIFAR Azrieli Global Scholar and Tier 2 Canada Research Chair in Gut Microbial Physiology in the Department of Microbiology and Immunology at McGill University. Board member of the Microbiome and Disease Tolerance Centre.

Research in our lab aims to address two major goals:
* Identify and characterize the metabolically active microbial members of the gut microbiota.
* Determine the role of bacteriophages as regulators of the active gut microbiota.

Ian R McDonald

BSc (Hons) University of Ulster, PhD Liverpool University. Postdoc and NERC Advanced Research Fellow at Warwick University. I have been at the University of Waikato since 2004 and was promoted to Professor in 2018. My research has focused on the microbial ecology of methane oxidation, Antarctica and geothermal environments in New Zealand. In Antarctica we are studying the drivers of microbial diversity in Dry Valley soils, geothermal environments (Mts Erebus, Melbourne and Rittmann), and terrestrial meltwater ponds. Currently ‘The 1000 Spring project’ is determining drivers of microbial diversity in NZ geothermal environments. I have organized several NZ and international conferences, I am currently the Chief Officer of SCAR Life Sciences.

Laurent Metzinger

Laurent Metzinger has completed his PhD in Biological Sciences and Pharmaceutical studies in Strasbourg, France and was a postdoctoral fellow from the University of Oxford (UK) in a leading lab on Duchenne muscular Dystrophy (Pr. Kay Davies). He works on microRNA regulation in the HEMATIM team in Amiens, and focuses on anemia and related vascular disorders associated with Chronic Kidney DIsease. He has authored some of the first papers showing a role for microRNAs in CKD and published in reputed journals, including Nature and Cell. He teaches Biochemistry, Genetics and Molecular Biology in the Pharmacy School of Amiens (Université de Picardie Jules Verne).

David Meyre

David Meyre completed a PhD in quantitative plant genetics in France. Since 2001, he has been working on the elucidation of the genetic bases of obesity and type 2 diabetes. In 2004, he published the first family-based genome-wide scans for childhood and severe adult obesity. He completed the two first successful positional cloning efforts for childhood and severe adult obesity, which identified the positional candidate genes ENPP1 and PCSK1. In 2007, he contributed to the identification of the major susceptibility gene for polygenic obesity FTO. In 2009, he published the first genome-wide association study of extreme obesity in the French population and identified four novel susceptibility-loci. In 2010, he conducted the first genome-wide association meta-analysis for early-onset extreme obesity in German and French populations. In 2012, he identified the third more common form of monogenic obesity (PCSK1 partial deficiency) and demonstrated an important role of the lipid sensor GPR120 in human obesity. He also discovered the first molecular link between obesity and major depression. In 2013, he discovered a novel gene (SIM1) responsible for a syndromic Mendelian form of childhood obesity. In 2016, he discovered that physical activity can blunt the effect of the obesity predisposing gene FTO in diverse ethnic groups. He also demonstrated that genes can predict the outcomes of different types of bariatric surgery.

Sumit Middha

Providing translational genomics + bioinformatics solutions for Next Generation Sequencing (NGS) big-data applications and interpretation of human variation for functional genomics and precision medicine.

Alexander S Mikheyev

I am principally interested in how ecological forces shape genomic evolution. To do this I have been taking advantage of ongoing developments in sequencing technology. I try to remain on the cutting edge of this fast-moving field by developing new molecular and analytical methods for sequencing, with a particular focus on degraded DNA, such as in museum specimens. I choose study organisms for their suitability to the project at hand, and have worked on everything from microorganisms, to insects to snakes. Despite this diversity, much of my work has focused on the biology of social insects, and they remain a personal passion.